Andy Collard has extensive experience in corporate development and strategic projects within the biotechnology and pharmaceuticals sectors. The professional background includes roles at TCR2 Therapeutics Inc. as Director of Corporate Development and Associate Director, as well as key positions at Novartis Institutes for BioMedical Research, where responsibilities encompassed directing strategic initiatives. Previous experience includes consulting and analytical roles at Back Bay Life Science Advisors and scientific work at Myriant Technologies, where metabolically engineered bacteria were developed for biochemical production. Andy Collard holds a Bachelor of Science in Molecular Biology from Yale University and an MBA with a healthcare concentration from Yale School of Management.
This person is not in the org chart
This person is not in any teams
This person is not in any offices